Industry Presentations
A Treatment Option in AChR/MuSK+ Generalized Myasthenia Gravis
Presentations
A targeted treatment option in myasthenia gravis
Speakers: Nicholas Silvestri, MD, FAAN, Associate Professor of Neurology Duration: 60 minutes
Presented on: March 11, 2024
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers
Nicholas Silvestri, MD, FAAN
Nicholas Silvestri, MD, FAAN
Associate Professor of Neurology
Nicholas Silvestri, MD, FAAN, is an Associate Professor of Neurology and Assistant Dean for Student and Academic Affairs at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences. Dr. Silvestri is board-certified in neurology, neuromuscular medicine, and electrodiagnostic medicine. He is the former program director of the adult neurology residency program. Over the past years, his research interests have included myasthenia gravis, diabetic neuropathy, and Guillain-Barre syndrome. Dr. Silvestri conducts both clinical research studies and basic science research in collaboration with physician-scientists from multiple disciplines. Moreover, he has authored over 50 peer-reviewed articles, book chapters, and textbooks and has presented talks nationally and internationally.